ATLASNervGen Pharma (NGEN) earnings date: Nov 12, 2026
NervGen Pharma (NGEN) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026. Analysts expect EPS of $0.01.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on NGEN
| Last price | $1.34 (-2.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.5% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 5 reports |
These figures come from the same calibrated model and valuation as the NervGen Pharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
NervGen Pharma reports on Nov 12, 2026. One email the day before, with ATLAS’s read on NervGen Pharma. You can switch it off at any time.
Alert me before NGEN reportsFree to start. Creating an account takes under a minute.
Notify me when NervGen Pharma reports
Track NGEN free Add NervGen Pharma to a free ATLAS watchlist and see its next report date in one place.
NGEN earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $0.01 |
| Last report | Aug 13, 2026 · Miss |
| Beat rate (last 5 reports) | 1 of 5 (20%) |
| Average EPS surprise | -107.8% |
| Average move around a report | ±5.9% (last 5) |
| Sector | Healthcare · Biotechnology |
NervGen Pharma earnings history: last 5 reports
NervGen Pharma last reported on Aug 13, 2026: EPS of -$0.23 against an estimate of -$0.07 (-228.6% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$0.07 | -$0.23 | -228.6% | Miss | -1.4% |
| May 15, 2026 | -$0.06 | -$0.07 | -16.7% | Miss | -1.9% |
| Apr 21, 2026 | $1.52 | $2.16 | +42.1% | Beat | +0.6% |
| Mar 31, 2026 | -$0.07 | -$0.27 | -285.7% | Miss | +16.9% |
| Aug 26, 2025 | -$0.06 | -$0.09 | -50.0% | Miss | -8.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for NGEN
See the fair value, the probability range and the earnings history of NervGen Pharma on its ATLAS page.
NervGen Pharma (NGEN) stock analysisPlans from €3.99 a month.
NervGen Pharma earnings: frequently asked questions
When does NervGen Pharma (NGEN) report earnings?
NervGen Pharma is scheduled to report on Thursday, November 12, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for NGEN?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $0.01 per share (USD). Estimates can change before the report.
How often does NGEN beat earnings estimates?
Of its last 5 reports with a recorded result, NervGen Pharma beat the EPS estimate 1 times; the average surprise was -107.8%. Past results do not predict the next one.
How much does NGEN move around earnings?
Over its last 5 reports the stock moved an average of 5.9% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did NervGen Pharma beat earnings estimates last quarter?
NervGen Pharma last reported on Aug 13, 2026: EPS of -$0.23 against an estimate of -$0.07 (-228.6% surprise), a miss.
How much does NGEN usually move in a day?
On a normal trading day the ATLAS model puts NGEN’s one-day range at about ±3.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer